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This pilot study provides the proof of principle for biomedical application of novel polyelectrolyte complexes (PECs) obtained
via electrostatic interactions between dextran sulphate (DXS) and poly(allylamine hydrochloride) (PAH). Scanning electron
microscopy (SEM) and atomic force microscopy (AFM) showed that DXS/PAH polyelectrolyte complexes were Monodispersed
withregularrounded-shapefeaturesandaveragediametersof250nmat2:1weightratiosofDXS/PAH.FluorescentlylabelledDXS
and ﬂuorescein-isothiocyanate- (FITC-)conjugate DXS were used to follow cell uptake eﬃciency of PECs and biodegradability of
their enzymatically degradable DXS-layers by using confocal laser scanning microscopy (CLSM). Moreover, quantitative MTT and
Trypan Blue assays were employed to validate PECs as feasible and safe nanoscaled carriers at single-cell level without adverse
eﬀects on metabolism and viability.
1.Introduction
Polymeric particles have sparked major interest as nanosized
delivery systems that increase drug’s retention eﬀects and
eﬃcacy at single-cell level through a temporal or spatial
control (targeted therapy)[ 1–3]. From a biological and
therapeutic perspective, the intrinsic advantage of these
supramolecular assemblies lies in the potential of acting as
biocompatible and biodegradable carriers under physiolog-
ical conditions [4–6]. Indeed, the use of polymers that are
biodegradable or can release their cargo in response to well-
deﬁned stimuli, enables small molecule drugs to be delivered
over an extended period of time, thus achieving eﬀective
therapeutic eﬀects at reduced drug concentrations or dosage
frequency [7–9]. Due to their versatility in templating
and surface coating, several polymeric nanosystems such
as polyelectrolyte capsules [10–12], polyionic complexes
(PICs), or polyelectrolyte complexes (PECs) are being largely
characterized by addressing their uptake kinetics and pro-
cessing in living human cells [13–16].
We herein describe a simple and reproducible procedure
to obtain the spontaneous formation of polyelectrolyte
complexes (PECs) by mixing oppositely charged polyions,
such as poly(allylamine hydrochloride) (PAH) and dex-
tran sulphate (DXS). The electrostatic interactions between
such polycations and polyanions in solution can be ﬁnely
tuned in the nanometer range by varying the strength and
location of ionic sites, polymer chain rigidity, precursor
chemistries, pH, temperature, and mixing intensity [15,
16] .T h ep h y s i o c h e m i c a lp r o p e r t i e so fP E C sw e r ee v a l u a t e d
by the measurement of particle size, ζ potential, atomic
force microscopy (AFM), and scanning electron microscopy
(SEM), showing that DXS/PAH polyelectrolyte complexes
were monodispersed with regular rounded-shape features2 Journal of Drug Delivery
and average diameters of 250nm. PAH was chosen as it
is a typical example of synthetic polycation that is insen-
sitive to the action of intracellular proteases, whereas the
polyanionDXScontainsprotease-sensitivebondsthatensure
the polymer’s erosion inside the cells. Moreover, confocal
laser scanning microscopy (CLSM) and several functional
approacheswereemployedtovalidatePECsasbiodegradable
nanoscaled carriers at single-cell level without adverse side
eﬀects on cell metabolism and viability.
2.MaterialsandMethods
2.1. Chemicals. The sources of the chemicals are as fol-
lows: poly(allylamine hydrochloride) (PAH, Sigma, USA,
CAS:71550-12-4), dextran sulfate sodium salt from Leu-
conostoc sppe (DXS, Sigma, USA, CAS:077K1027), Fluores-
cein isothiocyanate dextran (DXS-FITC, Sigma, USA, CAS:
20696KJ), formaldehyde solution (Sigma, USA, CAS:50-00-
0).
All tissue culture media and serum were purchased
from Sigma, cell lines were purchased from American
Tissue Type Collection (ATTC). The suppliers of the
chemicals were as follows: fetal bovine serum (FBS,
Sigma, USA, CAS:N/A), penicillin-streptomycin solution
(Sigma, USA, CAS:010M0651), L-glutamine 200mM
(Sigma, USA, CAS:56-85-9), DMEM medium (Sigma,
USA, CAS:N/A), sodium pyruvate (Sigma, USA, CAS:113-
24-6), Trypsin-EDTA solution (Sigma, USA, CAS:N/A),
thiazolyl blue tetrazolium bromide (MTT, Sigma, USA,
CAS:MKBB9557), phosphate buﬀered saline (PBS, Sigma,
USA, CAS:049K8204), Trypan Blue solution (Sigma, USA,
CAS:72-57-1), Fluoroshield with DAPI (Sigma, USA,
CAS:070M1418).
2.2. Synthesis of Polyelectrolyte Complexes (PECs). Polyelec-
trolyte complexes (PECs) were prepared according to Cheng
et al., 2009 [15]. Solution of DXS-FITC (2mg/mL in 0.1M
NaCl pH 6.5) was mixed with a solution of PAH (1mg/mL in
0.5MNaClpH6.5)underagitationandthemixturesolution
wasstirredslowlyatroomtemperaturefor2hours.Afterthis
period, the solution was dried in a lyophilisator and stored at
4◦C.
2.3. Polyelectrolyte Complexes Size and ζ Potential Measure-
ment. Dynamic light scattering (DLS) and zeta-potential
(ζ) measurements were performed on a Zetasizer Nano
ZS90 (Malvern, USA) equipped with a 4.0mW He-Ne
laser operating at 633nm and an avalanche photodiode
detector. Measurements were made at 25◦Ci na q u e o u s
solutions (pH 7). The PECs solution (1mg/mL) was passed
through a 0.45μm pore size ﬁlter before measurements
and appropriately diluted if necessary according to the
instrument’s requirements. Representative measurements of
three distinct sets of data have been reported (Student t- test,
P < 0.05).
2.4. Scanning Electron Microscopy (SEM). For SEM analysis
(RHAIT 150), samples were prepared by applying a drop
of the particle suspension to a SiO2 wafer and then drying
overnight. Prior to SEM observation, the samples were
sputter-coated with a 10nm gold layer to make them
electronically conductive and to avoid electronic charging
during SEM imaging.
2.5. Atomic Force Microscopy (AFM). The morphological
characterization has been performed by tapping mode AFM
using a Solver PRO Scanning Probe Microscope (NT-
MDT) in air at room temperature, we used TESPA (Veeco,
USA) silicon cantilevers of 20–80N/m spring constant and
resonance frequency of around 300kHz. A drop of sample
suspension was applied to a silicon support.
2.6. Cell Culture. Human ﬁbroblast cell line (BJ) and human
cervixcarcinomacellline(HeLa)weremaintainedinDMEM
supplemented with FBS (10%), penicillin (100U/mL culture
medium), streptomycin (100μg/mL culture medium), L-
glutamine (5%), and sodium pyruvate (5%). Cells were
grown in a humidiﬁed incubator at 37◦C, 5% CO2, and 95%
relative humidity.
2.7. PECs Uptake by HeLa and BJ Cells
2.7.1. Confocal Laser Scanning Microscopy (CLSM). To deter-
mine the cellular uptake of the PECs we seeded 105 cells/mL
in sterile glass-culture slide. The cells were incubated with
the PECs dispersions at a concentration of 0.05mg/mL.
After 3 hours of incubation at 37◦C, the culture medium
was removed, and the cells were washed three times
with phosphate buﬀered saline. For ﬂuorescent microscopic
observation, cells were ﬁxed in situ for 5 minutes in
3.7% formaldehyde and mounting with ﬂuoroshield with
DAPI. Confocal micrographs were taken with Leica confocal
scanning system mounted into a Leica TCS SP5 (Leica
Microsystem GmbH, Mannheim, Germany), equipped with
a 63 X oil immersion objective and spatial resolution of
approximately 200nm in x-y and 100nm in z.T h e3 D
confocal scanning is performed by reconstructing the pho-
toluminescence coming from diﬀerent focalized slices with
a sequential image acquisition. The optical sections were
collected in transverse x-z and y-z planes.
2.8. Cytotoxicity Analysis
2.8.1. MTT Assay. The MTT system is a reproducible
means of measuring the activity of living cells via mito-
chondrial dehydrogenase activity. The key component is
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bro-
mide. Mitochondrial dehydrogenases of viable cells cleave
the tetrazolium ring, yielding purple MTT formazan crystals
that are insoluble in aqueous solutions. The crystals can
be dissolved in acidiﬁed isopropanol. The resulting purple
solution is spectrophotometrically measured. An increase
in cell number results in an increase in the amount of
MTT formazan formed and an increase in absorbance. The
polyelectrolyte complexes suspension at 0.01, 0.03, 0.05,
0.1, 0.2mg/mL concentrations was diluted with appropriate
cultural medium. The MTT method of cell determination is
most useful when cultures are prepared in multiwell plates.
HeLa and BJ cells (105 cells/mL) were added to 24-wellJournal of Drug Delivery 3
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Scheme 1: Schematic illustration of the self-assembled poly(allylamine) (a) and dextran (b) polyelectrolyte complexes as drug and gene
delivery systems.
culture plates at 1000μL/well and incubated at 37◦Ci n5 %
CO2, 95% relative humidity for 24–48 and 72 hours with the
PECssuspension.Thecontrolwascompleteculturemedium.
After an appropriate incubation period, remove cultures
from incubator and aseptically add MTT solution in an
amount equal to 10% of the culture volume. Return cultures
to incubator and incubate for 3 hours. After the incubation
period, remove cultures from incubator and dissolve the
resulting MTT formazan crystals with acidiﬁed isopropanol
solution an equal culture volume. The plates should be read
within 1 hour after adding acidiﬁed isopropanol solution.
After the incubation time pipetting up and down may be
required to completely dissolve the MTT formazan crystals.
Spectrophotometrically measure absorbance a wavelength
of 570nm. Subtract background absorbance measured at
690nm.
The percentage viability was expressed as the relative
growth rate (RGR) by equation: RGR = (Dsample/Dcontrol) ∗
100% where Dsample and Dcontrol are the absorbances of the
sample and the negative control.
2.8.2. Trypan Blue Assay. Trypan Blue is one of the dye
exclusion procedures for viable cell counting. This method
is based on the principle that live (viable) cells do not take up
certaindyeswhereasdead(nonviable)cellsdo.Livecellswith
intact cell membranes are not colored. Because cells are very
selective in the compounds that pass through the membrane,
in a viable cell, Trypan Blue is not absorbed; however, it
traverses the membrane in a dead cell. Therefore, dead cells
are shown to be a distinctive blue color under a microscope,
and living cells are excluded from staining. For the trypan
blue assay, HeLa and BJ cells were added to 24-well culture
platesat1000μL/wellandincubatedat37◦Cin5%CO 2,95%
relative humidity for 24, 48, and 72 hours with PECs sus-
pension. The polyelectrolyte complexes suspension at 0.01,
0.03, 0.05, 0.1, 0.2mg/mL concentrations was diluted with
culture medium. The control was complete culture medium.
After the appropriate incubation period, the medium of each
sample was collected. After trypsinization, the cells were
collected and centrifuged. The pellet was resuspended in an
appropriate amount of medium. The collected cells were
mixed with the same volume of 0.4% trypan blue solution.
Cells were allowed to stand from 5 to 15 min. Later, 10μL
of stained cells was placed in a hemocytometer, and the
number of viable (unstained) and dead (stained) cells was
counted with a light microscope. The viability percentage
was expressed using the following equation: cell viability
(%) = total viable cells (unstained)/total cells (stained and
unstained) × 100. Representative measurements of three
distinct sets of data have been reported (t-Student test, P <
0.05).
3. Results and Discussion
3.1. Preparation and Characterization of Polyelectrolyte Com-
plexes(PECs). Dextran(DXS)isacomplex,branchedglucan
composed of chains of varying lengths (from 3 to 2000kDa).
The straight chain consists of α-1,6 glycosidic linkages
between glucose molecules, while branches begin from α-
1,3 linkages. DXS is commonly used by microsurgeons
to decrease vascular thrombosis. The antithrombotic eﬀect
of DXS is mediated through its binding of erythrocytes,
platelets, and vascular endothelium, increasing their elec-
tronegativity while reducing erythrocyte aggregation and
platelet adhesiveness [17].
Poly(allylamine), also named PAH, is a cationic poly-
electrolyte prepared by the polymerization of allylamine. It
can be used in combination with an anionic polyelectrolyte
like poly(sodium styrene sulfonate) to form a layer-by-
layer (LbL) adsorbed ﬁlm of negatively and positively
charged polymers. Poly(allylamine hydrochloride) has many
biomedical applications. The most prominent use of this
polyelectrolyteisintheﬁeldofcellencapsulation.Alayer-by-
layer method is used by alternating positively and negatively
charged polyelectrolytes to build a barrier between the cell
and the harsher outside environment. Upon cell lysis, the
capsule of layered polyelectrolytes maintains its structural
integrity and can be used for purposes such as drug delivery
[7–10].
These polyelectrolytes present diﬀerent chemical fea-
tures, in particular the DXS is a biocompatible and4 Journal of Drug Delivery
biodegradable polyelectrolyte while the PAH is biocompat-
ible and not biodegradable polyelectrolyte. In particular, the
intracellular degradation of biodegradable polyelectrolyte
(DXS) can lead to the release of therapeutic cargo into
cells, while the presence of biosynthetic polyelectrolyte can
function as reserve system of cargo [7].
Polyelectrolyte complexes (PECs) were obtained by mix-
inginequalvolumetwopolyelectrolytesolutions:DXS-FITC
at concentration of 2mg/mL and PAH at concentration of
1mg/mL.
DXS is a polyanion, while PAH is polycation and elec-
trostatic attraction occurs between them. In this study,
the self-assembly of DXS and PAH was conducted in
NaCl solution (pH 6.5). Under this condition, the above
two macromolecules having opposite charges were found
to self-assemble eﬀectively into PECs. The spontaneous
self-assembling of DXS/PAH into PECs was schematically
illustrated in Scheme 1. We have assumed that the formation
of PECs was a process involved mainly 3 steps. In the ﬁrst
step, the complex formation is mediated by Coulomb forces.
At the second step, the formation of new bonds and/or
the correction of the distortions inside the polymer’s chains
may occur within the complexes. Third, an inter-complexes
aggregation process may be mediated by the aggregation of
secondary complexes via hydrophobic interactions.
3.2. Particle Size and ζ Potential Measurements. Dynamic
Light Scattering (DLS) determined sizes of PECs resulted
in good agreement with SEM and AFM data (Figure 1). In
fact, PECs displayed a hydrodynamic diameter of 250nm
(Figure 2(a)). We have also investigated the stability of
PECs. Taking PECs during the ﬁrst two days, particle size
was almost unchanged, and even at 5 days, PECs did not
aggregate and their size remained lower, around 370nm
(Figure 2(b)). Furthermore, the good stability of PECs
supplied an opportunity for storage.
In addition, the PECs possessed a higher ζ potential,
around 32mV. The positive ζ potential of PECs made
complexes easier to be uptake by cells, attributed to the
electrostatic interactions between negative charged cellular
membranes and positive charged complexes.
3.3. AFM and SEM Characterization. The morphology of
PECs was observed by atomic force microscopy (AFM) and
scanning electron microscopy (SEM). It is evident from
Figure 1 that all the particles have a regular spherical shape
and as exhibited in this ﬁgure the particle size of the PECs is
approximately 250nm.
3.4. Cytotoxicity of PECs. For gene/drug delivery, vectors
should not induce cytotoxic eﬀects and the low cytotoxicity
of PECs is very important. Here, the cytotoxicity of PECs
(DXS/PAH 2:1) was evaluated in HeLa cells and BJ cells by
MTT test and Trypan Blue assay. We performed cytotoxicity
tests at diﬀerent time points (24, 48 or 72 hours) by using
diﬀerent concentrations of PECs (ranging from 0.01 to
0.2mg/mL). In particular, it was important to assess cyto-
toxicity of the nanocomplexes upon 24 hours of incubation
since the cells would be in an exponential growth phase
during this period and any toxicity that reﬂects inhibition of
proliferation and/or cell death would be clearly visible [18].
Cytotoxicity was evaluated based on cell viability relative
to controls as proposed by Kong et al. [19]:
(i) noncytotoxic: >90% cell viability,
(ii) slightly cytotoxic: 60–90% cell viability,
(iii) moderately cytotoxic: 30–59% cell viability,
(iv) severely cytotoxic: ≤30% cell viability.
Figures 3(a) and 4(a) show that cell viability of HeLa cells
against PECs was constant on 100% even the concentration
was 0.01mg/mL, 0.03mg/mL, 0.05mg/mL, 0.1mg/mL, and
0.2mg/mL, showing the much lower cytotoxicity of PECs
and therefore the viability of treated cells many nearby to
that nontreated cells as control; while, cell viability of BJ
cells decreased from 90% to 40% even the concentration
was 0.2mg/mL (Figures 3(b) and 4(b)). The discrepancy in
cytotoxicity that has been observed for the two cell lines
can be ascribed to the intrinsic characteristics of these cells,
since the cell lines used were derived from diﬀerent cell
contexts and expressed diﬀerently the molecular machinery,
HeLa cells derived from cervix cancer while BJ cell line
was established from skin taken from normal foreskin. In
order, factors aﬀecting cytotoxicity have been reported to
be molecular weight, charge density and type of cationic
functionality, structure and sequence (block, random, linear
and branched), and conformational ﬂexibility [20].
Since PECs did not impact on metabolism or viability
of the two cell lines analyzed, these novel materials could
have potential application as safe nanocarriers for gene/drug
delivery in neoplastic cells.
3.5. In Vitro Uptake. The presence of DXS-FITC allowed the
PECs uptake and localization into cancer cells (HeLa) and
normal cells (BJ). After 3 hours of incubation with FITC-
labelled PECs at concentration of 0.05mg/mL, HeLa cells
and BJ cells were observed by a confocal laser scanning
microscope (CLSM).
As shown in Figure 5, after 3 hours of incubation, strong
green ﬂuorescent staining can be observed, which means
PECshavebeendeliveredintoHeLacellsandBJcells.Thecell
uptakeofthePECswasconﬁrmedbyperformingscansalong
the Z axis of treated cells, thus showing the predominant
localization of the PECs into the cytoplasm of both cell types
analyzed. These ﬁndings can be explained by electrostatic
interactions between the positive surface charge of PECs
and the negatively charged cell plasma membrane followed
by spontaneous internalisation of PECs inside cells through
pinocytosis or endocytosis. This process is also referred to
as nonspeciﬁc adsorptive endocytosis. The binding of PECs
to may be essential for the following process of internaliza-
tion of the complexes, because the PECs surface was not
functionalized for speciﬁc binding by cells. Moreover, the
FITC-ﬂuorescence signal of PECs, although predominantly
associated with sulphated proteoglycan components of the
cell plasma membrane, clearly indicated a colocalization ofJournal of Drug Delivery 5
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Figure 1: AFM and SEM images of polyelectrolyte complexes ((a) and (b), resp.).
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Figure 2: Dynamic light scattering measurements (DLS) of PECs fresh (a) and after 5 days (b).
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Figure 3: MTT cytovitality test (at 24 to 48 to 72 hours) for the HeLa cells (a) and BJ cells (b), interacting with culture medium (i.e., not
treated, NT) and diﬀerent concentration of PECs. Representative measurements of three distinct sets of data have been reported (t-Student
test, P < 0.05).6 Journal of Drug Delivery
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Figure 4: Cell viability assayed by cellular membrane damage assessment using the Trypan Blue exclusion test of PECs in (a) HeLa and (b)
BJ cells. Percent cell viability versus PECs concentration for 24 to 48 to 72 hours. Representative measurements of three distinct sets of data
have been reported (t-Student test, P < 0.05).
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Figure 5: CLSM images of polyelectrolyte complex (PECs) intracellular uptake by (a) human normal ﬁbroblast cells (BJ) and (b) human
cervix carcinoma cell line (HeLa). In blue DAPI ﬂuorescence of nuclei. In green FITC ﬂuorescence of PECs. Each confocal image reports the
corresponding Z-stack optical sections (1, 2) to conﬁrm the PECs internalization. Scale bar: 50μm (a) and 25μm( b ) .
such nanoparticles with actin-like cytoskeletal structures or
cytosolicendosomalvesiclesthatareactivelyinvolvedintheir
intracellular traﬃcking and degradability.
4. Conclusion
In this study, novel PECs were prepared through an electro-
static interaction between DXS and PAH. These polymeric
complexeswerespontaneouslyinternalisedinnormalﬁbrob-
last cell line (BJ) and in cervical carcinoma (HeLa) cells,
showing a predominant cytoplasmatic localization. More
importantly, PECs were herein validated as biocompatible
and biodegradable carriers, hence promising gene/drug
delivery vehicles at single-cell level.
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